CHRS
Coherus Biosciences Inc
$2.29
Earnings Summary
Revenue | $74.57Mn |
Net Profits | $-39.64Mn |
Net Profit Margins | -53.16% |
Highlights
Coherus Biosciences Inc’s revenue jumped 64.16% since last year same period to $74.57Mn in the Q3 2023. On a quarterly growth basis, Coherus Biosciences Inc has generated 27% jump in its revenue since last 3-months.
Coherus Biosciences Inc’s net profit jumped 57.31% since last year same period to $-39.64Mn in the Q3 2023. On a quarterly growth basis, Coherus Biosciences Inc has generated 7.53% jump in its net profits since last 3-months.
Coherus Biosciences Inc’s net profit margin jumped 73.99% since last year same period to -53.16% in the Q3 2023. On a quarterly growth basis, Coherus Biosciences Inc has generated 27.19% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Coherus Biosciences Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.29 |
EPS Estimate Current Year | -0.29 |
Highlights
Coherus Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.29 - a -7.41% fall from last quarter’s estimates.
Coherus Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.29.
Key Ratios
Key ratios of the Coherus Biosciences Inc post its Q3 2023 earnings
Earning Per Share (EPS) | -0.41 |
Highlights
Coherus Biosciences Inc’s earning per share (EPS) jumped 57.29% since last year same period to -0.41 in the Q3 2023. This indicates that the Coherus Biosciences Inc has generated 57.29% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-08 | -0.57 | -0.75 | -31.58% |
2023-11-06 | -0.27 | -0.41 | -51.85% |
2023-08-02 | -0.48 | -0.38 | 20.83% |
₹0 US Stocks a/c Opening Fee